UnitedHealthcare TRT Coverage
in Washington — 2026 Guide
UHC covers testosterone therapy through its Medical Benefit Drug Policy. Learn the 2026 PA criteria, formulary tiers, and why UHC members pay just $0–20/month at Revive.
UnitedHealthcare (UHC) is the largest health insurer in the United States, covering tens of millions of Americans including a large share of Washington state residents through employer plans, individual policies, Medicare Advantage (AARP), and Medicaid managed care. For men with low testosterone, UHC offers solid coverage — with generic injectable testosterone at Tier 1, a 12-month PA approval, and a well-defined set of documentation criteria that Revive's clinical process is built to satisfy.
This guide covers UHC's 2026 TRT coverage rules in full — including the updated Medical Benefit Drug Policy that took effect January 1, 2026, the specific lab criteria required, and what UHC members realistically pay at the pharmacy.
UHC's 2026 Medical Benefit Drug Policy for Testosterone
UnitedHealthcare updated its Medical Benefit Drug Policy for Testosterone Replacement and Supplemental Therapy, effective January 1, 2026. This policy governs PA requirements for testosterone across most UHC commercial and Medicare Advantage plans. It specifies exactly what lab values and clinical documentation are needed for approval and provides 12-month authorizations when criteria are met.
UHC's 2026 PA criteria require ONE of the following lab thresholds:
- Two separate morning total testosterone draws both below 300 ng/dL, OR
- One free testosterone measurement below 50 pg/mL (for patients with borderline total T or elevated SHBG)
In addition, UHC requires documented evaluation to rule out reversible causes of low testosterone — thyroid disorders, sleep apnea, medication effects, significant weight changes, and other conditions that could explain suppressed androgen levels. This is reflected in our 51-analyte panel, which routinely includes thyroid function, metabolic markers, sleep disorder screening indicators, and HbA1c.
UHC free testosterone threshold: Unlike most carriers that focus solely on total testosterone, UHC's 2026 policy explicitly allows a low free testosterone (below 50 pg/mL) as a standalone criterion for PA approval. This benefits men with elevated SHBG who may have "normal" total T but clinically low bioavailable testosterone. Revive's lab panel includes both total and free testosterone by default.
UHC Formulary: What's Covered and What Isn't
On UHC's formulary, generic testosterone cypionate is placed at Tier 1 — meaning $0–20 per monthly fill for most members after deductible. This makes UHC one of the more favorable carriers for TRT medication cost.
- Tier 1 — Preferred Generic: $0–20 copay. Generic testosterone cypionate. Covered with PA.
- Tier 2 — Non-Preferred Generic: $25–50 copay. Some testosterone formulations may fall here depending on plan.
- Tier 3 — Preferred Brand: $60–120 copay. Brand topical products if covered.
Explicitly NOT covered under UHC's 2026 policy:
- Compounded testosterone: Explicitly classified as "experimental and investigational" — not covered under any circumstances.
- Brand Azmiro (testosterone undecanoate nasal gel): Specifically excluded from UHC's 2026 formulary.
As with all major carriers, UHC's explicit exclusion of compounded testosterone means that any telehealth TRT company using compounding pharmacies cannot bill UHC — and members pay out of pocket despite having coverage that would work with an FDA-approved prescription.
12-Month PA Approval and Annual Reauthorization
When UHC approves TRT coverage, the authorization is valid for 12 months. This means our team submits a PA request once per year rather than every 90 days, significantly reducing administrative burden. Reauthorization requires updated lab work showing that treatment is ongoing and appropriate — the same labs we collect at your regular follow-up visits.
Our team tracks PA expiration dates for all UHC patients and initiates reauthorization automatically before the approval lapses. You won't experience any gap in coverage between annual approvals.
UHC Plan Types and TRT Coverage
UHC Choice Plus (PPO)
The most common UHC employer plan in Washington. Full out-of-network access without referrals, extensive pharmacy network. Revive prescriptions can be filled at Walgreens, CVS, Costco, Fred Meyer, and most pharmacies in UHC's OptumRx network.
UHC Navigate (HMO)
HMO plans may require a PCP referral for specialist care, but the pharmacy benefit works the same. Your UHC HMO drug benefit applies to any prescription filled at an in-network pharmacy, regardless of where the prescription originated.
UHC Medicare Advantage (AARP)
UnitedHealthcare offers Medicare Advantage plans in Washington under the AARP brand. These plans include Part D drug coverage with formulary placement for generic testosterone. Medicare Advantage patients should also review our Medicare TRT coverage guide for additional context on Medicare-specific criteria.
UHC Marketplace Plans
ACA-compliant plans through Washington's Health Benefit Exchange. Generic testosterone must be covered under essential health benefits. Deductibles may be higher but copays after deductible are competitive.
Why UHC Members Choose Revive Over Telehealth
The math for UHC members: Revive Standard plan ($35/mo) + testosterone with UHC ($0–20/mo) = $35–55/mo total. Telehealth TRT with compounded testosterone (not covered by UHC) = $150–250/mo out of pocket. Annual savings: $1,200–2,600.
We Meet UHC's PA Documentation Requirements
UHC's 2026 policy requires comprehensive documentation of hormone levels, symptom history, and reversible cause exclusion. Our 51-analyte panel covers every lab UHC asks for — including total testosterone, free testosterone, LH, FSH, prolactin, thyroid function, metabolic panel, PSA, CBC, and HbA1c. Our clinical documentation is designed to satisfy UHC's criteria on the first submission.
We Handle All PA Paperwork
Prior authorization for UHC is submitted through the UHC provider portal (uhcprovider.com). Our team handles submission, follow-up, and reauthorization at no additional cost. Standard PA turnaround: 3–5 business days. Our UHC approval rate exceeds 92%.
Copay Estimates for UHC TRT Patients
Injectable Testosterone
Testosterone cypionate 200mg/mL. Tier 1 Preferred Generic. PA required, 12-month approval.
Topical Testosterone
Generic gel with PA. Brand products may require step therapy. Higher copay tier.
Common Questions From UHC Members
When did UHC's TRT policy change?
UHC's Medical Benefit Drug Policy for testosterone replacement therapy was updated effective January 1, 2026. Key changes include the explicit addition of free testosterone as an alternative qualifying criterion and clarification on reauthorization requirements. If you had a prior approval under the previous policy, your 2026 reauthorization will be processed under the updated criteria.
What if my UHC plan has a high deductible?
UHC HDHP plans pair with HSA accounts for pre-tax medical savings. Before your deductible, you pay UHC's negotiated rate for generic testosterone — typically $30–50 per fill. After your deductible, Tier 1 copay of $0–20 applies. HSA funds can be used for all TRT-related expenses including Revive membership.
Can UHC decline testosterone if "levels are normal"?
UHC's policy uses a specific threshold (total T below 300 ng/dL OR free T below 50 pg/mL), not just "normal range" — which can vary by lab. If your values fall below these thresholds with documented symptoms, UHC is obligated to review the PA under their policy criteria. Our clinical team ensures your documentation meets these specific numeric thresholds before submitting.
Getting Started as a UHC Member
- Step 1: Book your first visit ($99) — physician consultation + comprehensive 51-analyte lab panel (includes total T, free T, LH, FSH, thyroid, HbA1c, and all UHC-required markers).
- Step 2: Bring your UHC card — we verify your formulary tier, deductible, and PA requirements.
- Step 3: We submit PA under UHC's 2026 Medical Benefit Drug Policy. Standard approval: 3–5 business days.
- Step 4: Pick up your testosterone at Tier 1 — typically $0–20/month for a 12-month authorization.
For full insurance coverage details, visit our insurance coverage page. To understand how our 51-analyte lab panel covers every UHC documentation requirement, see our lab testing page.
Related Insurance Guides
UHC Member? We've Got You Covered.
Book your first visit for $99 — includes a physician consultation and comprehensive lab work. We'll handle UHC prior authorization and get your medication covered under the 2026 policy.
Or call us: (206) 960-4770 · Seattle · Kirkland · Federal Way